CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 41 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Dexmedetomidine 1 mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01195116
NCT01195116Phase 4Completed
CompareCT.gov

Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis

University of Rochester·interventional·Posted Sep 3, 2010·Updated Apr 15, 2015

In Brief

A Phase 4 clinical trial evaluating Dexmedetomidine and Normal Saline for Interstitial Cystitis. Completed, enrolled 41 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent will result in better postoperative pain management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInterstitial Cystitis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 3, 2010
Enrollment StartMay 1, 2010
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 15.8 years ago

Interventions

Dexmedetomidinedrug

1 mcg/kg/hour

Normal Salinedrug

1mcg/kg/hr